Advanced Medical Solutions (AMS)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 14.2 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 2.16 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Dec | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Last ex-div: 1st May, paid: 28th May more... Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | +26.8% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Advanced Medical Solutions Group plc revenues increased 53% to L52.6M. Net income increased 100% to L9.7M. Revenues reflect Branded Direct segment increase from L5.7M to L20.1M, OEM segment increase of 18% to L22M, Branded distributed segment increase of 89% to L6.8M, Germany segment increase from L3.2M to L13.9M, Rest of Europe segment increase of 36% to L16.9M. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 2 | 2 | 4 |
Advanced Medical Solutions Group plc is involved in the design, development, licensing, manufacture and distribution of polymers (both natural and synthetic) for use in advanced woundcare dressings and materials, and medical adhesives, for closing and sealing tissue. It distributes its products to the global device market by selling to healthcare companies, distributors and directly into the hospital and dental market in Germany, the Czech Republic and Russia and to the National Health Service (NHS) in the United Kingdom. The Company operates in two segments: advanced woundcare, whose principal activities are the research, development, manufacture and distribution of, polymers for use as wound dressings, and wound closure and sealants, whose principal activities are the research, development, manufacture and distribution of medical adhesives and products for closing and sealing tissue. On December 22, 2011, the Company acquired RESORBA.
Directors: Andrew Meredith (CEO) , Mary Tavener (Fin. Dir.) , Richard Stenton (VP-Op.) , Richard Smith (VP) , Jeffrey Willis (VP) , Clare Holden (VP) , Steve Platt (GM) , Pieter Van-Hoof (GM) , Ian Vickery (Other) ,
No. of Employees: 453 No. of Shareholders: n/a
| Last Annual | December 31st, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 204,633,339 |
| Free Float | 184.5m (90.1%) |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share, FTSE Aim 100, FTSE Aim UK 50, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | Road Three,Winsord Industrial Estate, WINSFORD, CW7 3RT, United Kingdom |
| Web | http://www.admedsol.com/ |
| Phone | +44 1606 863500 |
| Contact | Mary G Tavener (Secy.) |
| Registrar | Capita Registrars Limited (Huddersfield) |
| Auditors | Deloitte LLP |
| 6th Mar | Final Results |
| 26th Feb | Notice of Results |
| 20th Feb | Holding(s) in Company |
| 31st Jan | Total Voting Rights |
| 18th Jan | Holding(s) in Company |
| 16th Jan | Holding(s) in Company |
Recent ↓
